Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against ...

Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

The home of a prominent Bayer executive was targeted last week in an alleged arson in New Jersey, law enforcement sources ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...

Bayer's CEO, Bill Anderson, faces escalating investor scrutiny to reverse the company's forecasted earnings decline. Tasked ...

The center, which broke ground in 2023 in the Beijing Economic-Technological Development Area — aka Beijing E-Town — is the ...

SALES FORECAST: The German pharmaceutical and agricultural conglomerate is expected to post sales of 11.26 billion euros ($11.71 billion) for the quarter ended December, according to a Vara Research ...

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. Grünenthal is ...

The stock plunged by as much as 10% in intraday trading on Friday with investors balking at the size of a cash call as ...

Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules ...

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an “improved trajectory” next year.